New horizons in management of rheumatic diseases related ILD - Prof. Dinesh Khanna - RheumaCon 2021
Therapies on the Horizon for RA ILD
New Directions in the Diagnosis of RA ILD
Updates on Current Treatment Options for RA ILD
Horizon Announces First Patient Enrolled in Diffuse Cutaneous Systemic Sclerosis Study
WSF 1st Webinar on ILD - SSc
Screening and Management of Cardiovascular Disease in Rheumatoid Arthritis, by Dr. Jon Giles
Progress in Diagnosis and Management of Scleroderma Lung Disease
Interstitial Lung Disease
Scleroderma101: Newly Diagnosed, Flavia Castelino, MD
New Horizon in the Management of Depression
Scleroderma and the Lung, Kristin B. Highland, M.D., M.S.C.R.
Medical Advisory Board Town Hall Dermatomyositis Interstitial Lung Disease AntiSynthetase Syndr
RNL 2021 - EULAR 2019 and ACR 2020 RA Treatment Guidelines - Dr. Alan Matsumoto
Optimizing outcomes in IMIDs: Focus on Co-Morbidities
Scleroderma Lung Disease, Jerry Molitor, M.D., Ph.D., University of Minnesota Medical School
RNL 2021: Glucocorticoids in RA: Past, Present, Future - Dr. Frank Buttgereit
2018 KGS2!: Research, What’s on the Horizon? - A. Stevens, MD, PhD; S. Li MD, PhD and K. Torok, MD
Diana Cejas' Story: The Lingering Lump
